These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33045109)

  • 1. Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes.
    Filippini A; Mutti V; Faustini G; Longhena F; Ramazzina I; Rizzi F; Kaganovich A; Roosen DA; Landeck N; Duffy M; Tessari I; Bono F; Fiorentini C; Greggio E; Bubacco L; Bellucci A; Missale M; Cookson MR; Gennarelli M; Russo I
    Glia; 2021 Mar; 69(3):681-696. PubMed ID: 33045109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRP10 and α-synuclein transmission in Lewy body diseases.
    Carreras Mascaro A; Grochowska MM; Boumeester V; Dits NFJ; Bilgiҫ EN; Breedveld GJ; Vergouw L; de Jong FJ; van Royen ME; Bonifati V; Mandemakers W
    Cell Mol Life Sci; 2024 Feb; 81(1):75. PubMed ID: 38315424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between astrocytes and microglia results in increased degradation of α-synuclein and amyloid-β aggregates.
    Rostami J; Mothes T; Kolahdouzan M; Eriksson O; Moslem M; Bergström J; Ingelsson M; O'Callaghan P; Healy LM; Falk A; Erlandsson A
    J Neuroinflammation; 2021 Jun; 18(1):124. PubMed ID: 34082772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve.
    Uemura N; Yagi H; Uemura MT; Hatanaka Y; Yamakado H; Takahashi R
    Mol Neurodegener; 2018 May; 13(1):21. PubMed ID: 29751824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron reduces the propagation of pathological α-synuclein: An Editorial Highlight for "Brain iron enrichment attenuates α-synuclein spreading after injection of preformed fibrils" on page 554.
    Guo YJ; Ayton S; Lei P
    J Neurochem; 2021 Nov; 159(3):414-416. PubMed ID: 34296424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological inhibition and knockdown of O-GlcNAcase reduces cellular internalization of α-synuclein preformed fibrils.
    Tavassoly O; Yue J; Vocadlo DJ
    FEBS J; 2021 Jan; 288(2):452-470. PubMed ID: 32365408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy?
    De Nuccio F; Kashyrina M; Serinelli F; Laferrière F; Lofrumento DD; De Giorgi F; Ichas F
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collusion of α-Synuclein and Aβ aggravating co-morbidities in a novel prion-type mouse model.
    Lloyd GM; Dhillon JS; Gorion KM; Riffe C; Fromholt SE; Xia Y; Giasson BI; Borchelt DR
    Mol Neurodegener; 2021 Sep; 16(1):63. PubMed ID: 34503546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy.
    Schaser AJ; Stackhouse TL; Weston LJ; Kerstein PC; Osterberg VR; López CS; Dickson DW; Luk KC; Meshul CK; Woltjer RL; Unni VK
    Acta Neuropathol Commun; 2020 Aug; 8(1):150. PubMed ID: 32859276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein Fibrils.
    Creed RB; Goldberg MS
    Neuroscience; 2020 Jun; 437():64-75. PubMed ID: 32353461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive uptake of α-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage.
    Lindström V; Gustafsson G; Sanders LH; Howlett EH; Sigvardson J; Kasrayan A; Ingelsson M; Bergström J; Erlandsson A
    Mol Cell Neurosci; 2017 Jul; 82():143-156. PubMed ID: 28450268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production.
    Tapias V; Hu X; Luk KC; Sanders LH; Lee VM; Greenamyre JT
    Cell Mol Life Sci; 2017 Aug; 74(15):2851-2874. PubMed ID: 28534083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson's disease.
    Yang Y; Song JJ; Choi YR; Kim SH; Seok MJ; Wulansari N; Darsono WHW; Kwon OC; Chang MY; Park SM; Lee SH
    Proc Natl Acad Sci U S A; 2022 Jul; 119(29):e2110746119. PubMed ID: 35858361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson's Disease.
    Huang R; Gao Y; Duan Q; Zhang Q; He P; Chen J; Ma G; Wang L; Zhang Y; Nie K; Wang L
    Mol Neurobiol; 2023 Feb; 60(2):979-1003. PubMed ID: 36394710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
    Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
    Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance.
    Streubel-Gallasch L; Giusti V; Sandre M; Tessari I; Plotegher N; Giusto E; Masato A; Iovino L; Battisti I; Arrigoni G; Shimshek D; Greggio E; Tremblay ME; Bubacco L; Erlandsson A; Civiero L
    Mol Neurobiol; 2021 Jul; 58(7):3119-3140. PubMed ID: 33629273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice.
    Gu XL; Long CX; Sun L; Xie C; Lin X; Cai H
    Mol Brain; 2010 Apr; 3():12. PubMed ID: 20409326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.